Marcol invests in Fernarzt, launches new HealthHero platform

Seed investor Heartbeat Labs will retain a 10% stake in Fernarzt and will remain a strategic partner for the German market, according to a statement.

Marcol acquired UK-based remote GP service Medical Solutions, which will form part of HealthHero’s UK-based operations, in July 2017. Santander provided funding for the acquisition via a growth capital loan.

According to a statement, Medical Solutions has seen demand for its services in the UK and the Republic of Ireland increase by 300% during the coronavirus pandemic.

Previous funding
Heartbeat Labs invested in Fernarzt in 2017 to assist with the operational launch of the company.

Company
Founded in 2017, Fernarzt is a Germany-based telemedicine company that allows users to fill out a questionnaire and subsequently receive prescriptions via the company’s deliver service. Fernarzt launched its video consultation service in June 2020 and has also added coronavirus-related services, including antibody tests. The company has 15 employees, according to LinkedIn.

People
HealthHero – Ranjan Singh (CEO).
Fernarzt – Felix Kaiser (managing director).
Heartbeat Labs – Johannes Keienberg (managing director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Exits
• DACH
• Technology
• Secondary buyout
• Germany
• coronavirus